Literature DB >> 1505787

Limited protection against iron-induced lipid peroxidation by cord blood plasma.

J H Lindeman1, E Houdkamp, E G Lentjes, B J Poorthuis, H M Berger.   

Abstract

The ability of plasma from newborn babies (cord blood) and adults to inhibit iron-induced lipid peroxidation was compared. The caeruloplasmin and transferrin concentrations, and latent iron-binding capacity were lower in the babies (p less than 0.001). The plasma of many of the babies had no latent iron-binding capacity and contained non-protein-bound iron (measured by the bleomycin assay). The in vitro ability of plasma to inhibit iron-induced liposome peroxidation by either ferroxidase antioxidant activity (caeruloplasmin) or iron-binding antioxidant activity (transferrin) was measured. The antioxidant activity in both assays was decreased in the babies (p less than 0.001). The percentage inhibition of peroxidation in the iron-binding antioxidant assay correlated positively with the latent iron-binding capacity (p less than 0.001) and negatively with the presence of bleomycin-detectable iron (p less than 0.02) in the babies. This assay produced stimulation of peroxidation in 42% of the babies but none of the adults. The diminished capacity of cord blood plasma to prevent iron-induced lipid peroxidation may predispose the newborn baby to the toxic effects of oxygen.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1505787     DOI: 10.3109/10715769209049181

Source DB:  PubMed          Journal:  Free Radic Res Commun        ISSN: 8755-0199


  3 in total

Review 1.  Antioxidants in neonatal lung disease.

Authors:  C H Fardy; M Silverman
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-09       Impact factor: 5.747

2.  Transient iron overload with bleomycin detectable iron in the plasma of patients with adult respiratory distress syndrome.

Authors:  J M Gutteridge; G J Quinlan; T W Evans
Journal:  Thorax       Date:  1994-07       Impact factor: 9.139

Review 3.  The Free Radical Diseases of Prematurity: From Cellular Mechanisms to Bedside.

Authors:  Serafina Perrone; Antonino Santacroce; Mariangela Longini; Fabrizio Proietti; Francesco Bazzini; Giuseppe Buonocore
Journal:  Oxid Med Cell Longev       Date:  2018-07-24       Impact factor: 6.543

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.